FEATURED CONTRIBUTED CONTENT

The Innovation Imperative: The Future of Drug Development


The Innovation Imperative: The Future of Drug Development

The impact of innovation is evident across a number of industries but has not been fully realized within the pharmaceutical industry. With rising R&D costs, a more crowded marketplace and increased focus on value demonstration, developers face mounting pressure in bringing drugs to market. Yet, opportunity exists to meet the growing health needs of the […]

August 30, 2018 More Clinical »
The Evolution of Bioanalytical Outsourcing Partnerships


The Evolution of Bioanalytical Outsourcing Partnerships

By Jim Datin, President and CEO, BioAgilytix Bioanalytical outsourcing has changed dramatically in the past 30 years, which isn’t surprising when you consider how our economy, the healthcare market, technology, and drugs themselves have changed in that same period. In order to keep up with external market pressures and the complexity of emerging large molecule […]

August 21, 2018 More Clinical »
The Power of Insight


The Power of Insight

Good insight gives you the tools to create innovative products and services that meet customers’ needs at the point of need, transforming lives. However, many organisations find distilling large swathes of data into meaningful insights challenging. Download the white paper to learn: Tools for easily bringing your research to life How to turn data into […]

September 13, 2018 More Clinical »
Building a Secure, Automated Quality System to Accelerate Time to Market


Building a Secure, Automated Quality System to Accelerate Time to Market

Today life science companies face a perfect storm of factors driving their costs up and sales down. With 40% of R&D costs linked to paper-based processes, legacy, manual processes pose a particular threat – costing life science companies billions of dollars a year and delaying product launch and commercialization*. Boston Scientific is tackling these challenges […]

October 18, 2018 More Clinical »
Clinical Trials in Children with Impaired Mental Capacity


Clinical Trials in Children with Impaired Mental Capacity

In the majority of clinical trials we undertake, the consent process is fairly straightforward; however, complex situations do arise. Pediatric clinical trials present unique challenges, as do those in patients who lack legal competence. In the instance of a mentally impaired child, it is important to determine the best approach for obtaining consent and assent as early as possible […]

September 10, 2018 More Clinical »
Addressing Unmet Needs of Patients and Providers in Rare and Complex Disease


Addressing Unmet Needs of Patients and Providers in Rare and Complex Disease

As the growth of rare and complex disease continues to skyrocket, more than ever, pharmaceutical manufacturers must address the unique challenges of providers and their patients to differentiate their brand. Providers and their staff have a lack of knowledge; they face continued time constraints, and with the growth of new products it’s difficult to keep […]

September 27, 2018 More Clinical »
The EU HTA Harmonization Initiative: What is the Significance to Manufacturers of the New Directive?


The EU HTA Harmonization Initiative: What is the Significance to Manufacturers of the New Directive?

Comparative clinical benefit assessments are at the core of Health Technology Assessments (HTAs) in Europe. HTAs are a multi-disciplinary process considering input and evidence from medical, social, and economic sources. They are used to inform the design of health policies that allow the safe and effective use of new technologies within individual health systems and […]

September 24, 2018 More Clinical »
The Future of Work is Now. Are you Ready?


The Future of Work is Now. Are you Ready?

In today’s rapidly changing market, organizations and workforce experts alike are trying to determine how the future of work will transform. Based on conversations across the market and our in-depth research, KellyOCG has determined that there are four dimensions organizations need to consider when contemplating the “Future of Work”: technology, the workforce (including the multiple […]

September 25, 2018 More Clinical »
Clinical Trials in Children with Impaired Mental Capacity


Clinical Trials in Children with Impaired Mental Capacity

PRA has written a new white paper on conducting clinical trials with adolescents, specifically children with impaired mental capacity. In the majority of clinical trials we undertake, the consent process is fairly straightforward; however, we do conduct studies in patients who lack legal competence. This occurs most frequently in pediatric patients; in these cases the lack of […]

September 10, 2018 More Clinical »
Prescribe Robust Distribution to Commercialize Your Orphan Drug


Prescribe Robust Distribution to Commercialize Your Orphan Drug

Finding a home for your biopharmaceutical company’s new orphan drug doesn’t just happen after it is FDA approved. The successful commercialization of your promising new drug requires a focused and well-planned distribution model. But first, some background. Orphan drugs treat rare diseases or medical conditions that affect fewer than 200,000 people a year in the […]

September 17, 2018 More Clinical »
Adapting the Functional Services Model to Deliver Flexible Solutions


Adapting the Functional Services Model to Deliver Flexible Solutions

A mid-sized multinational client had historically resourced its monitoring services with multiple providers, including Covance, but wanted to move to one preferred partner for each of its global regions with a Functional Service Provider (FSP) model.

September 24, 2018 More Clinical »
Challenges in Thought Leader Management – Data Analytics and Technology Can Help


Challenges in Thought Leader Management – Data Analytics and Technology Can Help

Optimize the value of engagements with advanced analytics and proprietary, technology-enabled identification and profiling techniques.

August 31, 2018 More Clinical »
Driving Drug Development Innovation Through Patient Centricity


Driving Drug Development Innovation Through Patient Centricity

The Innovation Imperative: The Future of Drug Development, is a recent data-driven report developed and released by The Economist Intelligence Unit and commissioned by PAREXEL. The report examines drug development today and evaluates innovations that can accelerate clinical trials, increase likelihood of launch and patient access and improve the productivity of drug development. The report […]

August 30, 2018 More Clinical »
Breakthrough Drug Development Innovations: Increasing the Likelihood of Market Launch


Breakthrough Drug Development Innovations: Increasing the Likelihood of Market Launch

By: Sy Pretorius, Chief Scientific & Medical Officer, PAREXEL Drug development today is facing serious challenges. The way new treatments are brought to market has become increasingly inefficient, lengthy and costly, with a high likelihood of failure. Meanwhile, pressures are mounting on companies to bring therapies to patients more quickly and cost effectively than ever […]

September 7, 2018 More Clinical »
Avoid Enrollment Pitfalls by Engaging with Best-Fit Sites


Avoid Enrollment Pitfalls by Engaging with Best-Fit Sites

Perhaps the single most important consideration in selecting a site is whether it can make its enrollment. Many don’t; in fact, 20-25 percent of all clinical studies close because they fail to meet enrollment targets.1 For decades, sponsors have found their “best fit” sites and returned to them for future studies. But in the era […]

September 1, 2018 More Clinical »
Unlocking the potential of online communities – looking beyond the surface


Unlocking the potential of online communities – looking beyond the surface

While online communities have emerged as a critical component of understanding the experiences of people living with chronic conditions, there is so much more to learn and uncover beneath the surface. In this webinar, Health Union, a pioneer in creating open, online health communities (19 and counting), including migraine.com, multiplesclerosis.net and lungcancer.net, discusses the how […]

September 20, 2018 More Clinical »
Medical Storytelling: Combining High Science and High Emotion for High Impact


Medical Storytelling: Combining High Science and High Emotion for High Impact

During this presentation, the speakers will share their insights on transforming medical education content from a package insert rehash into a compelling, compliant medical story. They will highlight how you can take healthcare provider audiences from being passive listeners to active participants by Capturing and keeping their attention, reception, and recall Provocatively challenging healthcare providers […]

October 17, 2018 More Clinical »
Utilizing a Protocol Cost Saving Analysis to Reduce Drug Development Costs


Utilizing a Protocol Cost Saving Analysis to Reduce Drug Development Costs

Over the years, studies have been conducted to ascertain the cost of research and development (“R&D”) required to bring a new drug to market. Experts disagree on the exact amount, but the consensus is that the figure is in the hundreds of millions to over a billion dollars. Pharmaceutical companies, biotech firms and anyone in […]

August 21, 2018 More Clinical »
FEEDBACK